Renaissance of MMPs as therapeutic targets? Maybe.
Matrix metalloproteases (MMPs) have been implicated in a number of different human diseases and are currently one of the actively pursued targets in drug discovery and development. In this issue of Structure, Udi and colleagues describe how an inhibitory antibody, LEM-2/15, affects a member of the MMP family, MT1-MMP.